Abstract
Background:
As children living with HIV (CWH) achieve longer life expectancy, they face an emerging ‘double burden’ of infectious and non-communicable diseases, specifically pediatric overweight and obesity (OW/OB). This risk is exacerbated by weight-inducing Integrase Strand Transfer Inhibitors (INSTIs). We systematically reviewed family-based pediatric weight management interventions for CWH aged 6 to 12 globally.
Methods:
Following PRISMA guidelines (PROSPERO: CRD42024554376), we searched Medline, Embase, and Cochrane (2007-2024) for clinic-linked behavioral interventions reporting body composition or behavioral outcomes.
Results:
From 1026 records and 7 full-text reviews, no studies met the inclusion criteria. Excluded studies lacked clinical integration or targeted adult populations.
Conclusion:
This ‘null’ finding represents a critical evidence gap and clinic concern: CWH receive weight-inducing medications without evidence-based behavioral support. Future research must prioritize integrating care models using implementation science frameworks (RE-AIM/CFIR) to bridge the gap between primary HIV care and obesity management in resource-constrained settings.
Keywords: HIV, pediatrics, weight management, obesity, global health, systematic review
Background
Pediatric overweight and obesity (OW/OB) is a pandemic 1 ; over the past 3 decades, its prevalence has quadrupled, with 80% of the burden affecting lower- and middle-income-countries (LMICs). 2 In these regions, HIV remains a concurrent public health priority. As antiretroviral therapy (ART) allows children living with HIV (CWH) to survive into adolescence and beyond they face an emerging dual risk of infectious disease and non-communicable comorbidities, with obesity and malnutrition often co-existing within the same communities. While the World Health Organization (WHO) and emerging research has redefined HIV as chronic disease, the co-occurrence of obesity and HIV are leading causes of early mortality among individuals under 18 years old in regions like South Africa.3-5
There is a critical need to develop interventions aimed at reducing premature mortality from cardiometabolic diseases in children living with HIV (CWH), particularly the 12 million CWH in sub-Saharan Africa. This need is significantly amplified by the global transition to Integrase Strand Transfer Inhibitor (INSTI)-based regimens, such as Dolutegravir, which is now the preferred first-line ART regimen in nearly all LMICs due to its high genetic barrier to resistance and superior efficacy, which have been independently linked to accelerated weight gain in pediatric cohorts.6-8 This creates a clinical vacuum: while millions of children are being transitioned to life-sustaining, weight-inducing medications as a matter of global policy, there is an absence of evidence-based behavioral interventions tailored to mitigate these cardiometabolic side effects.
Evidence from adult populations demonstrates that integrated approaches addressing HIV alongside non-communicable diseases (NCDs) can be effective and feasible in managing mental health, hypertension, and diabetes.9-16 However, a significant research gap remains for pediatric populations, where integrative approaches for HIV and obesity have not yet been explored. Landmark reports and the most recent 2023 clinical practice guidelines 17 highlights that children aged 6 years and older benefit from family-based, multi-component behavioral interventions, especially when informed by theoretical frameworks (eg, Social Cognitive Theory, Chronic Care Model for Childhood Obesity).17-25 While these guidelines emphasize primary care clinics as the principal site for obesity-related assessment and diagnosis, no guidelines specifically address obesity management for CWH. 26 Consequently, while family-based interventions are effective in the general pediatric public, their application for CWH, particularly in LMICs, is unexplored.17,20-25
Primary care clinics are the essential hub where CWH receive their primary and HIV-specific care (eg, HIV antiretroviral therapy, HIV viral load testing), especially in LMICs.17,27-29 Implementation science (IS) is an emerging field for optimizing care within sub-Saharan Africa. 9 IS models such as the Reach, Effectiveness, Adoption, Implementation, Maintenance (RE-AIM) Framework 30 are increasingly used to guide and evaluate interventions to improve the adoption, delivery, and sustainment of evidence-based interventions such as integrated HIV and non-communicable disease evidence-based practices.31-33 However, no specific recommendations for managing OW/OB in CWH have been made despite an increased focus on managing comorbidities, 17 highlighting an urgent need for targeted, theory-driven interventions.
Methods
Adhering to the Preferred Reporting Items for Systematic Review and Meta-Analyses (PRISMA) guidelines,34,35 this systematic review was registered with the International Prospective Register of Systematic Reviews (PROSPERO) on June 15, 2024 (CRD42024554376). We collaborated with a medical research librarian, who is experienced in systematic literature review, to design a comprehensive search of relevant studies from January 2007 to June 2024 (see Appendix 1).36,37 For this systematic review, we used Ovid Medline, Embase, and Cochrane Library which are key databases for searching health-related literature, building on the framework established by prior research. 38 Searches were completed on June 17, 2024, and the results were uploaded to Covidence for screening. Additionally, we also reviewed the reference lists of the included studies for any other studies that were not identified in the database search for further eligibility assessment.
The inclusion and exclusion criteria were carefully defined a priori, based on the established PICOTS framework (population, intervention, comparison, outcome, timing, and setting), 39 and further informed by the Reach, Effectiveness, Adoption, Implementation, and Maintenance (RE-AIM) framework (see Supplement 1).30,40 These criteria were strategically crafted to ensure the selection of the most relevant studies. The eligibility criteria were determined by the following: (1) interventions were conducted in and/or connected to a primary care setting, (2) family-based approaches, (3) participant outcomes focused on changes in body composition (eg, BMI percentile) and/or behavioral changes in both children and parents (eg, FNPA score) (4) case reports, study protocols, commentaries, editorials, and non-peer-reviewed articles were excluded, and (5) studies must be published in English.
Search results were managed using Covidence software. Two team members independently reviewed each abstract against the established eligibility criteria. Those appropriate for consideration by at least 1 reviewer were selected for full-text screening. Each full-text article was then independently reviewed for eligibility by at least 2 team members, with any disagreements resolved after team discussion and through consensus. To ensure the reliability of the selection process, Kappa statistics were calculated to measure the level of inter-rater reliability or agreement for article inclusion. For studies that met the inclusion criteria, a single investigator meticulously extracted data on PICOTS and RE-AIM characteristics (see Supplement 2) into an Excel spreadsheet, with a second team member conducting a thorough dual review to ensure accuracy and consistency.
Ethical Approval and Informed Consent
Ethics approval was not required for this systematic review.
Results
A total of 1026 studies were imported for screening, and 265 were identified as duplicates by Covidence. Of the 761 titles and abstracts screened, 752 were removed, primarily due to irrelevant study outcomes. Of the 7 full-text studies assessed for eligibility, no articles met the inclusion criteria (see Figure 1). During the first round of review, the inter-rater reliability was 0.98, reflecting a high level of agreement among reviewers. In the second round, the inter-rater reliability increased to 1, indicating perfect agreement. Among the articles reviewed, 1 article 41 highlighted the role of pediatricians advocating for childhood OW/OB. Another study focused on OW/OB in pregnant women. 42 A third study examined children ages 0 to 5 with OW/OB but did not discuss HIV. 43 Additionally, 4 out of the 7 studies (57%) were excluded given their lack of connection to healthcare facilities and instead described the CIrCLE of Life Initiative, a school-based educational intervention aimed at addressing childhood OW/OB and HIV in sixth-grade children.44-47
Figure 1.
PRISMA 2020 flow diagram for new systematic reviews.
Discussion
The obesity pandemic continues to grow disproportionally, affecting individuals in LMICs who now face the double burden of infection and non-communicable comorbidities. A significant portion of this population consists of CWH, who are now living longer and increasingly affected by OW/OB. Our systematic review identifies a stark and concerning reality: despite the urgent clinical need, there is currently an absence of evidence-based, family-based behavioral interventions tailored specifically for CWH aged 6 to 12.
The absence of eligible interventions in our review is particularly alarming given the global transition to Integrase Strand Transfer Inhibitor (INSTI)-based regimens. Recent cohort data have confirmed that transitioning to Dolutegravir is independently associated with accelerated weight gain and increased BMI z-scores in pediatric populations.6-8 This ‘INSTI Paradox’—where life-sustaining treatment contributes to long-term cardiometabolic risk—creates a clinical vacuum. Specifically, clinicians are effectively prescribing weight-inducing medications without offering evidence-based and tailored behavioral/lifestyle interventions to mitigate those side effects. Without data-informed strategies, CWH face increasingly preventable health risks, including early-onset hypertension and diabetes.
Barriers and Contextual Realities
Several factors likely contribute to this research gap. First, structural and funding barriers in LMICs prioritize acute HIV management, leaving limited resources for co-morbid interventions. Second, the complex needs and competing priorities of HIV antiretroviral therapy (ART) and obesity management may deter researchers from implementing family-based obesity interventions.
Third, existing care models, such as the Chronic Care Model and implementation science frameworks like the Consolidated Framework for Implementation Research (CFIR) and RE-AIM, have largely been applied in high-income countries, limiting their direct translation to resource-constrained settings. 9 Contextual and cultural differences necessitate interventions that are locally adapted, yet such tailoring requires significant investment in formative research and community engagement.
Lessons from the Field: Clinic Versus Community
It is essential to consider the context of healthcare interventions across diverse global settings. Models such as the Obesity Chronic Care Model 48 emphasize clinic-based interventions in promoting OW/OB behavior change. However, our review noted that in the Global South, effective outreach may need to occur outside of the traditional clinical setting.
Innovative examples, such as the CIrCLE of Life Initiative in South Africa, demonstrate the feasibility of community- and school-based interventions targeting OW/OB and HIV in children.44-47 While these were excluded from our primary analysis because they were not clinic-linked, they offer valuable lessons for integrating obesity prevention into broader pediatric HIV care frameworks and underscore the need for flexible intervention models that account for local realities.
Strengths
First, guided by an implementation science lens,49,50 this review focused on an understudied and highly vulnerable population. Second, the review was conducted by a transdisciplinary authorship team of clinicians and researchers from the Global South and North, ensuring diverse perspectives in its development and analysis. The review team conducted this review in accordance with evidence-based practices (PRISMA).
Limitations
Several limitations of this review should be acknowledged. First, the requirement that interventions be connected to a healthcare provider or healthcare system may have limited the scope of our review, especially given that a school-based intervention was identified. This criterion aligns with clinic-based care models 51 that were developed in the Global North and may not fully apply to the Global South. Second, while more than 90% of peer-reviewed articles are published in English, 52 it is possible that relevant studies published in other languages were not included in this review. Third, publication bias could be possible, as research with significant findings is more likely to be published.
Future Directions
Future research could expand on this review by exploring school- and community-based interventions as valid adjuncts to clinical care. Adopting an implementation science lens and drawing from Kenneth Rothman’s the Sufficient-Component Cause Model, 53 it will be crucial to reevaluate evidence-based guidelines and models to identify which practices are universally necessary and which components may be more context-specific, particularly in different global populations and settings.
Call to Action and Opportunities
Addressing pediatric obesity among CWH demands urgent, transdisciplinary, coordinated action across research, clinical practice, and policy domains (Table 1):
Table 1.
Strategic Roadmap for Addressing the Dual Burden of HIV and Pediatric Obesity.
| Domain | Key strategies | Priority actions | Expected impact |
|---|---|---|---|
| Research | Evidence generation and adaptations | Develop and pilot family-based, multi-component interventions specifically for CWH. | Validated, culturally tailored intervention protocols that address the specific metabolic needs of CWH. |
| Utilize RE-AIM and CFIR frameworks to evaluate feasibility in resource-limited settings. | |||
| Expand research to school- and community-based ‘hybrid’ models. | |||
| Clinical practice | Service integration | Designate primary care clinics as integrated hubs for both HIV and NCD management. | Early identification of weight-related complications and reduction in long-term cardiometabolic morbidity. |
| Standardize routine BMI screening and metabolic monitoring (glucose/lipids) during ART visits. | |||
| Train providers in culturally sensitive behavioral counseling. | |||
| Health system | Capacity building | Train a transdisciplinary workforce (nurses, CHWs, nutritionists) on the ‘double burden’ of malnutrition. | Improved health worker self-efficacy and more holistic, patient-centered pediatric care. |
| Incorporate dietary and physical activity guidance into the standard Pediatric HIV Care Package. | |||
| Policy and funding | Systemic advocacy | Secure dedicated funding for NCD-HIV integration (eg, via PEPFAR or Global Fund). | Sustainable, institutionalized support and scaled reach of obesity prevention programs. |
| Update national and supranational (eg, WHO) guidelines to include obesity management for CWH. | |||
| Foster cross-sector partnerships between Ministries of Health and Education. | |||
| Equity | Justice-oriented metrics | Implement equity-focused metrics to monitor outcomes across different socio-economic and geographic strata. | Reduction in health disparities and equitable access to next-generation HIV care. |
| Ensure interventions are accessible to rural and highly marginalized populations. |
(1) Research Priorities: Develop and evaluate family-based, multi-component interventions targeting CWHs in LMICs using IS frameworks like CFIR and RE-AIM to guide adaptation and delivery
(2) Clinical and Health Systems Integration: Leverage primary care settings as hubs for integrated HIV and obesity management. This includes training providers to recognize the ‘double burden’ of malnutrition and incorporating behavioral counseling into routine HIV care.
(3) Policy and Funding Strategies: Advocate for dedicated funding streams and encourage supranational health entities (eg, WHO) to include integrated pediatric obesity interventions in official HIV programing guidelines.
Conclusion
CWH in LMICs face a pressing, yet under-recognized, dual burden of malnutrition and obesity. The absence of family-based interventions for this population highlights a critical research and implementation gap. Urgent action is needed to design, evaluate, and scale interventions that address both HIV and pediatric obesity in an equitable, context-sensitive manner to prevent early morbidity and improve long-term health outcomes for some of the world’s most vulnerable children.
Supplemental Material
Supplemental material, sj-docx-1-gph-10.1177_30502225261421700 for The Gap in Integrated Pediatric Care: A Systematic Review of Family-Based Weight Management for Children Living with HIV by Joshua S. Yudkin, Christopher Owens, James Gilbreath and Charles Martyn-Dickens in Sage Open Pediatrics
Acknowledgments
We would like to thank Megan Bell who peer-reviewed the search. We would also like to thank Drs. Izat and Nguyen for their editorial assistance.
Appendix 1
Search Strategy
Pediatric Obesity and HIV
Research Questions
What is the effectiveness of family-based behavioral pediatric weight management interventions on BMI-related and behavioral outcomes?
How have implementation science outcomes of family-based behavioral pediatric weight management interventions been measured?
MEDLINE via Ovid
(Deselecting ‘Include related terms’ and ‘Include media’)
Ovid MEDLINE(R) ALL <1946 to June 14, 2024>
Pediatrics/or Child/or Child Health/or Child Health Services/or (Pediatric* or paediatric* or child* or schoolchild* or kid or kids or preteen* or ‘pre-teen*’ or youth* or juvenile*).ti,kw,kf,ab. 2 937 909
Obesity/or obesity, morbid/or pediatric obesity/or body weight/or overweight/or Body Mass Index/or (obese* or obesity* or weight* or ‘overweight*’ or ‘body mass index*’ or BMI).ti,kw,kf,ab. 1 875 527
Family/or PARENTING/or Social Environment/or Child Rearing/or Child Care/or parents/or fathers/or mothers/or Legal Guardians/or Parent-Child Relations/or Family Relations/or Caregivers/or (famil* or guardian* or parent* or mother* or father* or childrear* or ‘child rear*’ or ‘child care*’ or dyad* or caregiver*).ti,kw,kf,ab. 2 146 943
Psychosocial Intervention/or Socioenvironmental Therapy/or exp Weight Reduction Programs/or Health Promotion/or health fairs/or patient education as topic/or Risk Reduction Behavior/ 185 361
((famil* or guardian* or parent* or mother* or father* or matern* or paternal* or psychosocial* or ‘psycho-social*’ or communit* or dyad* or home or socioenvironment* or ‘socio-environment*’) adj3 (interven* or treat* or approach* or method* or based or partner* or focus* or measur* or engag* or involvement* or therap*)).ti,kw,kf,ab 366 495
((weight* or diet or diets or dietary or health* or lifestyle* or ‘life-style*’ or obesity) adj3 (promot* or program* or interven* or counsel* or activit* or class* or classes* or manag*)).ti,kw,kf,ab. 406 460
4 or 5 or 6867 384
exp HIV/or exp HIV Infections/or (hiv or hiv+ or ‘human immunodeficiency virus*’ or ‘human immune deficiency virus*’ or AIDS or ‘acquired immunodeficiency syndrome’ or ‘HIV/AIDS’ or ‘acquired immune deficiency syndrome’ or ‘Lymphadenopathy Associated Viruses’ or ‘HTLV-III-LAV’ or ‘HTLV-III’ or PLHIV or PLWH or PLWHA or ‘T-Lymphotropic Virus Type III’ or WLHIV or ‘human T-cell lymphotropic’).ti,kw,kf,ab. 518 090
1 and 2 and 3 and 7 and 8 279
9 and 2007:2024.(sa_year). 213
Embase via Embase.com
Embase
Session Results
.......................................................
| No. | Query Results | Results | Date |
| #10 | #9 AND (2007:py OR 2008:py OR 2009:py OR 2010:py OR 2011:py OR 2012:py OR 2013:py OR 2014:py OR 2015:py OR 2016:py OR 2017:py OR 2018:py OR 2019:py OR 2020:py OR 2021:py OR 2022:py OR 2023:py OR 2024:py) |
686 | 17 Jun 2024 |
| #9. | #1 AND #2 AND #3 AND #7 AND #8 | 776 | 17 Jun 2024 |
| #8. | ‘human immunodeficiency virus’/exp OR ‘human immunodeficiency virus infection’/exp OR hiv:ti,ab,kw OR hiv+:ti,ab,kw OR ‘human immunodeficiency virus*’:ti,ab,kw OR ‘human immune deficiency virus*’:ti,ab,kw OR aids:ti,ab,kw OR ‘acquired immunodeficiency syndrome’:ti,ab,kw OR ‘acquired immune deficiency syndrome’:ti,ab,kw OR ‘hiv/aids’:ti,ab,kw OR ‘lymphadenopathy associated viruses’:ti,ab,kw OR ‘htlv-iii-lav’:ti,ab,kw OR ‘htlv-iii’:ti,ab,kw OR plhiv:ti,ab,kw OR plwh:ti,ab,kw OR plwha:ti,ab,kw OR ‘t-lymphotropic virus type iii’:ti,ab,kw OR wlhiv:ti,ab,kw OR ‘human t-cell lymphotropic’:ti,ab,kw |
1,082,961 | 17 Jun 2024 |
| #7. | #4 OR #5 OR #6 | 1 653 780 | 17 Jun 2024 |
| #6. | ((weight* OR diet OR diets OR dietary OR health* OR lifestyle* OR ‘life-style*’ OR obesity) NEAR/3 (promot* OR program* OR interven* OR counsel* OR activit* OR class* OR classes* OR manag*)):ti,ab,kw |
502 759 | 17 Jun 2024 |
| #5. | ((famil* OR guardian* OR parent* OR mother* OR father* OR matern* OR paternal* OR psychosocial* OR ‘psycho-social*’ OR communit* OR dyad* OR home OR socioenvironment* OR ‘socio-environment*’) NEAR/3 (interven* OR treat* OR approach* OR method* OR based OR partner* OR focus* OR measur* OR engag* OR involvement* OR therap*)):ti,ab,kw |
506 787 | 17 Jun 2024 |
| #4. | ‘psychosocial intervention’/exp OR ‘psychotherapy’/exp OR ‘weight loss program’/exp OR ‘health promotion’/exp OR ‘health education’/exp OR ‘risk reduction’/exp |
841 162 | 17 Jun 2024 |
| #3. | ‘family’/exp OR ‘child parent relation’/exp OR ‘social environment’/exp OR ‘child rearing’/exp OR ‘child care’/exp OR ‘parent’/exp OR ‘father’/exp OR ‘mother’/exp OR ‘legal guardian’/exp OR ‘family relation’/exp OR ‘caregiver’/exp OR famil*:ti,ab,kw OR guardian*:ti,ab,kw OR parent*:ti,ab,kw OR mother*:ti,ab,kw OR father*:ti,ab,kw OR childrear*:ti,ab,kw OR ‘child rear*’:ti,ab,kw OR ‘child care*’:ti,ab,kw OR dyad*:ti,ab,kw OR caregiver*:ti,ab,kw |
3 419 999 | 17 Jun 2024 |
| #2. | ‘obesity’/exp OR ‘morbid obesity’/exp OR ‘childhood obesity’/exp OR ‘body weight’/exp OR obese*:ti,ab,kw OR obesity*:ti,ab,kw OR weight*:ti,ab,kw OR ‘overweight*’:ti,ab,kw OR ‘body mass index*’:ti,ab,kw OR bmi:ti,ab,kw |
2 908 154 | 17 Jun 2024 |
| #1. | ‘pediatrics’/exp OR ‘child’/exp OR ‘child health’/exp OR ‘child health care’/exp OR pediatric*:ti,ab,kw OR paediatric*:ti,ab,kw OR child*:ti,ab,kw OR schoolchild*:ti,ab,kw OR kid:ti,ab,kw OR kids:ti,ab,kw OR preteen*:ti,ab,kw OR ‘pre-teen*’:ti,ab,kw OR youth*:ti,ab,kw OR juvenile*:ti,ab,kw |
4 465 586 | 17 Jun 2024 |
.......................................................
Cochrane
Search Name: Yudkin Pediatric Obesity HIV
Date Run: 18/06/2024 02:44:38
Comment:
| ID Search | Hits |
| #1 MeSH descriptor: [Pediatrics] explode all trees | 1047 |
| #2 MeSH descriptor: [Child] explode all trees | 82 092 |
| #3 MeSH descriptor: [Child Health] explode all trees | 272 |
| #4 MeSH descriptor: [Child Health Services] explode all trees | 1271 |
| #5 (Pediatric* OR paediatric* OR child* OR schoolchild* OR kid OR kids OR preteen* OR (pre NEXT teen*) OR youth* OR juvenile*):ti,ab,kw | 221 068 |
| #6 #1 OR #2 OR #3 OR #4 OR #5 | 221 236 |
| #7 MeSH descriptor: [Obesity] explode all trees | 21 407 |
| #8 MeSH descriptor: [Obesity, Morbid] explode all trees | 2018 |
| #9 MeSH descriptor: [Pediatric Obesity] explode all trees | 2167 |
| #10 MeSH descriptor: [Body Weight] explode all trees | 40 534 |
| #11 MeSH descriptor: [Overweight] explode all trees | 25 077 |
| #12 MeSH descriptor: [Body Mass Index] explode all trees | 14 064 |
| #13 (obese* or obesity* or weight* or overweight* or (body NEXT mass NEXT index*) or BMI):ti,ab,kw | 228 147 |
| #14 #7 OR #8 OR #9 OR #10 OR #11 OR #12 OR #13 | 228 502 |
| #15 MeSH descriptor: [Family] explode all trees | 14 832 |
| #16 MeSH descriptor: [Parenting] explode all trees | 2132 |
| #17 MeSH descriptor: [Social Environment] explode all trees | 5549 |
| #18 MeSH descriptor: [Child Rearing] explode all trees | 181 |
| #19 MeSH descriptor: [Child Care] explode all trees | 1250 |
| #20 MeSH descriptor: [Parents] explode all trees | 8753 |
| #21 MeSH descriptor: [Fathers] explode all trees | 318 |
| #22 MeSH descriptor: [Mothers] explode all trees | 3336 |
| #23 MeSH descriptor: [Legal Guardians] explode all trees | 115 |
| #24 MeSH descriptor: [Parent-Child Relations] explode all trees | 2697 |
| #25 MeSH descriptor: [Family Relations] explode all trees | 4656 |
| #26 MeSH descriptor: [Caregivers] explode all trees | 3845 |
| #27 (famil* OR guardian* OR parent* OR mother* OR father* OR childrear* OR (child NEXT rear*) OR (child NEXT care*) OR dyad* OR caregiver*):ti,ab,kw | 142 196 |
| #28 #15 OR #16 OR #17 OR #18 OR #19 OR #20 OR #21 OR #22 OR #23 OR #24 OR #25 OR #26 OR #27 | 146 974 |
| #29 MeSH descriptor: [Psychosocial Intervention] explode all trees | 277 |
| #30 MeSH descriptor: [Socioenvironmental Therapy] explode all trees | 4607 |
| #31 MeSH descriptor: [Weight Reduction Programs] explode all trees | 1136 |
| #32 MeSH descriptor: [Health Promotion] explode all trees | 8951 |
| #33 MeSH descriptor: [Health Fairs] explode all trees | 8 |
| #34 MeSH descriptor: [Patient Education as Topic] explode all trees | 10 867 |
| #35 MeSH descriptor: [Risk Reduction Behavior] explode all trees | 2383 |
| #36 #29 OR #30 OR #31 OR #32 OR #33 OR #34 OR #35 | 25 484 |
| #37 ((famil* OR guardian* OR parent* OR mother* OR father* OR matern* OR paternal* OR psychosocial* OR (psycho NEXT social*) OR communit* OR dyad* OR home OR socioenvironment* OR (socio NEXT environment*)) NEAR/3 (interven* or treat* or approach* or method* or based or partner* or focus* or measur* or engag* or involvement* or therap*)):ti,ab,kw | 75 757 |
| #38 ((weight* OR diet OR diets OR dietary OR health* OR lifestyle* OR (life NEXT style*) OR obesity) NEAR/3 (promot* OR program* OR interven* OR counsel* OR activit* OR class* OR classes* OR manag*)):ti,ab,kw | 93 255 |
| #39 #36 OR #37 OR #38 | 165 860 |
| #40 MeSH descriptor: [HIV] explode all trees | 4231 |
| #41 MeSH descriptor: [HIV Infections] explode all trees | 17 783 |
| #42 (hiv OR (human NEXT immunodeficiency NEXT virus*) OR (human NEXT immune NEXT deficiency NEXT virus*) OR AIDS OR ‘acquired immunodeficiency syndrome’ OR (HIV NEXT AIDS) OR ‘acquired immune deficiency syndrome’ OR ‘Lymphadenopathy Associated Viruses’ OR ‘HTLV-III-LAV’ OR ‘HTLV-III’ OR PLHIV OR PLWH OR PLWHA OR ‘T-Lymphotropic Virus Type III’ OR WLHIV OR ‘human T-cell lymphotropic’):ti,ab,kw | 39 274 |
| #43 #40 OR #41 OR #42 | 39 274 |
| #44 #6 AND #14 AND #28 AND #39 AND #43 | 139 |
Restricted date range for 01/01/2007 to 17/06/2024 for Cochrane Reviews, which resulted in 4 exported Cochrane Reviews out of 4 results
Restricted date range for 2007 to 2024 for Clinical Trials, which resulted in 123 exported trials out of 135 results
Footnotes
ORCID iDs: Joshua S. Yudkin 
https://orcid.org/0000-0001-9168-5145
Christopher Owens
https://orcid.org/0000-0002-2729-151X
James Gilbreath
https://orcid.org/0000-0001-7843-7403
Charles Martyn-Dickens
https://orcid.org/0000-0002-6659-9111
Author Contributions: Joshua S. Yudkin: Conceptualization, Methodology, Writing – Original Draft. Dr. Yudkin ideated the study, contributed to the review of articles, and prepared the original draft of the manuscript. Christopher Owens: Writing – review and editing. Dr. Owens provided significant editorial input and writing support throughout the manuscript development process. James Gilbreath: Methodology, resources. As the library scientist, Mr. Gilbreath led the development of the search strategy and ensured access to necessary resources. Charles Martin-Dickens: Investigation, writing – review and editing. Dr. Martin-Dickens served as the second reviewer for articles and contributed to manuscript revisions and edits. All authors have read and approved the final manuscript and agree to be accountable for all aspects of the work.
Funding: The authors disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This work was partially supported by the Fogarty International Center of the National Institutes of Health (NIH) under Award Number D43TW012274.
The authors declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.
Supplemental Material: Supplemental material for this article is available online.
References
- 1. Ben-Sefer E. The childhood obesity pandemic: promoting knowledge for undergraduate nursing students. Nurse Educ Pract. 2009;9(3):159-165. [DOI] [PubMed] [Google Scholar]
- 2. World Health Organization. Obesity and Overweight. World Health Organization. 2024. Accessed June 13, 2024. https://www.who.int/news-room/fact-sheets/detail/obesity-and-overweight#:~:text=The%20worldwide%20prevalence%20of%20obesity,of%205%20years%20were%20overweight [Google Scholar]
- 3. Chandiwana N, Venter WF, Manne-Goehler JM, et al. Obesity is South Africa’s new HIV epidemic. S Afr Med J. 2024;114:e1927. [DOI] [PubMed] [Google Scholar]
- 4. Kamkuemah M, Gausi B, Oni T. High prevalence of multimorbidity and non-communicable disease risk factors in South African adolescents and youth living with HIV: implications for integrated prevention. S Afr Med J. 2022;112(4):259-267. [PubMed] [Google Scholar]
- 5. Statistics South Africa. Mortality and Causes of Death in South Africa: Findings From Death Notification, 2022. Statistics South Africa; 2024. [Google Scholar]
- 6. The Epidemiology of Pregnancy and Paediatric Infections International Cohort Collaboration (EPPICC) Study Group. Changes in Body Mass Index in children and adolescents living with human immunodeficiency virus in Europe and Thailand starting dolutegravir. Open Forum Infect Dis 2025;12(12):ofaf640. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7. Thivalapill N, Simelane T, Mthethwa N, et al. Transition to dolutegravir is associated with an increase in the rate of body mass index change in a cohort of virally suppressed adolescents. Clin Infect Dis. 2021;73(3):e580-e586. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8. Esber AL, Chang D, Iroezindu M, et al. Weight gain during the dolutegravir transition in the African Cohort Study. J Int AIDS Soc. 2022;25(4):e25899. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9. Kemp CG, Weiner BJ, Sherr KH, et al. Implementation science for integration of HIV and non-communicable disease services in sub-Saharan Africa: a systematic review. AIDS. 2018;32 Suppl 1:S93-S105. [DOI] [PubMed] [Google Scholar]
- 10. Wissow LS, Tegegn T, Asheber K, et al. Collaboratively reframing mental health for integration of HIV care in Ethiopia. Health Policy Plan. 2015;30(6):791-803. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11. Duffy M, Sharer M, Cornman H, Pearson J, Pitorak H, Fullem A. Integrating mental health and HIV services in zimbabwean communities: a nurse and community-led approach to reach the most vulnerable. J Assoc Nurses AIDS Care. 2017;28(2):186-198. [DOI] [PubMed] [Google Scholar]
- 12. Iheanacho T, Obiefune M, Ezeanolue CO, et al. Integrating mental health screening into routine community maternal and child health activity: experience from prevention of mother-to-child HIV transmission (PMTCT) trial in Nigeria. Soc Psychiatry Psychiatr Epidemiol. 2015;50:489-495. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13. Dos Santos M, Wolvaardt G. Integrated intervention for mental health co-morbidity in HIV-positive individuals: a public health assessment. Afr J AIDS Res. 2016;15(4):325-331. [DOI] [PubMed] [Google Scholar]
- 14. Wagner GJ, Ngo V, Goutam P, Glick P, Musisi S, Akena D. A structured protocol model of depression care versus clinical acumen: a cluster randomized trial of the effects on depression screening, diagnostic evaluation, and treatment uptake in Ugandan HIV clinics. PLoS One. 2016;11(5):e0153132. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15. Chamie G, Kwarisiima D, Clark TD, et al. Leveraging rapid community-based HIV testing campaigns for non-communicable diseases in rural Uganda. PLoS One. 2012;7(8):e43400. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16. Venables E, Edwards JK, Baert S, Etienne W, Khabala K, Bygrave H. “They just come, pick and go.” The acceptability of integrated medication adherence clubs for HIV and non communicable disease (NCD) patients in Kibera, Kenya. PLoS One. 2016;11(10):e0164634. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17. Hampl SE, Hassink SG, Skinner AC, et al. Clinical Practice guideline for the evaluation and treatment of children and adolescents with obesity. Pediatrics. 2023;151(2):e2022060641. [DOI] [PubMed] [Google Scholar]
- 18. Ash T, Agaronov A, Young T, Aftosmes-Tobio A, Davison KK. Family-based childhood obesity prevention interventions: a systematic review and quantitative content analysis. Int J Behav Nutr Phys Act. 2017;14(1):113. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19. Cygan H, Reed M, Lui K, Mullen M. The chronic care model to improve management of childhood obesity. Clin Pediatr. 2018;57(6):727-732. [DOI] [PubMed] [Google Scholar]
- 20. Expert Panel on Integrated Guidelines for Cardiovascular Health and Risk Reduction in Children and Adolescents; National Heart, Lung, and Blood Institute. Expert panel on integrated guidelines for cardiovascular health and risk reduction in children and adolescents: summary report. Pediatrics. 2011;128(Suppl 5):S213-S256. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21. Canadian Task Force on Preventive Health Care. Recommendations for growth monitoring, and prevention and management of overweight and obesity in children and youth in primary care. CMAJ. 2015;187(6):411-421. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22. Nicholson WK, Silverstein M, Wong JB, et al. Interventions for high body mass index in children and adolescents: US Preventive Services Task Force recommendation statement. JAMA. 2024;332(3):226-232. [DOI] [PubMed] [Google Scholar]
- 23. Grossman DC, Bibbins-Domingo K, Curry SJ, et al. Screening for obesity in children and adolescents: US Preventive Services Task Force Recommendation Statement. JAMA. 2017;317(23):2417-2426. [DOI] [PubMed] [Google Scholar]
- 24. Epstein LH, Paluch RA, Roemmich JN, Beecher MD. Family-based obesity treatment, then and now: twenty-five years of pediatric obesity treatment. Health Psychol. 2007;26(4):381-391. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25. Janicke DM, Steele RG, Gayes LA, et al. Systematic review and meta-analysis of comprehensive behavioral family lifestyle interventions addressing pediatric obesity. J Pediatr Psychol. 2014;39(8):809-825. [DOI] [PubMed] [Google Scholar]
- 26. Aarons GA, Sklar M, Mustanski B, Benbow N, Brown CH. “Scaling-out” evidence-based interventions to new populations or new health care delivery systems. Implement Sci. 2017;12:111-113. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27. WHO, UNAIDS. The AIDS Response and Primary Health Care: Linkages and Opportunities. Technical series on Primary Health Care. World Health Organization; 2018. [Google Scholar]
- 28. Munderi P, Grosskurth H, Droti B, Ross DA. What are the essential components of HIV treatment and care services in low and middle-income countries: an overview by settings and levels of the health system? AIDS. 2012;26 Suppl 2:S97-S103. [DOI] [PubMed] [Google Scholar]
- 29. Kredo T, Ford N, Adeniyi FB, Garner P. Decentralising HIV treatment in lower- and middle-income countries. Cochrane Database Syst Rev. 2013;2013(6):CD009987. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30. Glasgow RE, Vogt TM, Boles SM. Evaluating the public health impact of health promotion interventions: the RE-AIM framework. Am J Public Health. 1999;89(9):1322-1327. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31. Glasgow RE, Harden SM, Gaglio B, et al. RE-AIM planning and evaluation framework: adapting to new science and practice with a 20-year review. Front Public Health. 2019;7:64. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32. Damschroder LJ, Reardon CM, Opra Widerquist MA, Lowery J. Conceptualizing outcomes for use with the Consolidated Framework for Implementation Research (CFIR): the CFIR Outcomes Addendum. Implement Sci. 2022;17(1):7. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33. Neta G, Brownson RC, Chambers DA. Opportunities for epidemiologists in implementation science: a primer. Am J Epidemiol. 2018;187(5):899-910. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34. Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Int J Surg. 2010;8(5):336-341. [DOI] [PubMed] [Google Scholar]
- 35. Parums DV. Editorial: review articles, systematic reviews, meta-analysis, and the updated preferred reporting items for systematic reviews and meta-analyses (PRISMA) 2020 guidelines. Med Sci Monit. 2021;27:e934475. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36. Alia KA, Wilson DK, McDaniel T, et al. Development of an innovative process evaluation approach for the families improving together (FIT) for weight loss trial in African American adolescents. Eval Program Plann. 2015;49:106-116. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 37. Tomayko EJ, Tovar A, Fitzgerald N, et al. Parent involvement in diet or physical activity interventions to treat or prevent childhood obesity: an umbrella review. Nutrition. 2021;13(9):3227. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 38. Yudkin JS, Koym K, Hamad Y, et al. Family-based pediatric weight management interventions in US primary care settings targeting children ages 6–12 years old: a systematic review guided by the RE-AIM framework. Transl Behav Med. 2024;14(1):34-44. [DOI] [PubMed] [Google Scholar]
- 39. Samson D, Schoelles KM. Developing the topic and structuring systematic reviews of medical tests: utility of PICOTS, analytic frameworks, decision trees, and other frameworks. J Gen Intern Med. 2012;27:11-19. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 40. Gaglio B, Shoup JA, Glasgow RE. The RE-AIM framework: a systematic review of use over time. Am J Public Health. 2013;103(6):e38-e46. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 41. Wacker J, Bosley E, Bolling C. The pediatrician’s role in community advocacy for Childhood Obesity Prevention. Pediatr Ann. 2014;43(9):e225-e229. [DOI] [PubMed] [Google Scholar]
- 42. Taylor NJ, Sahota P, Sargent J, et al. Using intervention mapping to develop a culturally appropriate intervention to prevent childhood obesity: the HAPPY (Healthy and Active Parenting Programme for Early Years) study. Int J Behav Nutr Phys Act. 2013;10:142. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 43. Lockner DW, Kibbe D, Marley SC, Trowbridge F. Get healthy together: a program to improve counseling for childhood obesity in community-based WIC clinics. J Health Care Poor Underserved. 2014;25(2):771-786. [DOI] [PubMed] [Google Scholar]
- 44. Arthur K, Christofides N, Nelson G. Development of a pre-adolescent inter-generational intervention to address HIV and obesity using intervention mapping. Health Educ J. 2020;79(8):932-947. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 45. Arthur K, Christofides N, Nelson G. Educators’ perceptions of organisational readiness for implementation of a pre-adolescent transdisciplinary school health intervention for inter-generational outcomes. PLoS One. 2020;15(1):e0227519. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 46. Arthur K, Christofides N, Nelson G. Effectiveness of a pre-adolescent inter-generational intervention to address HIV and obesity in South Africa, using a pretest-posttest design. BMC Public Health. 2021;21(1):2251. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 47. Arthur K, Christofides N, Nelson G. Process evaluation of a pre-adolescent transdisciplinary health intervention for inter-generational outcomes. PLoS One. 2021;16(12):e0261632. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 48. Dietz WH, Solomon LS, Pronk N, et al. An integrated framework for the prevention and treatment of obesity and its related chronic diseases. Health Aff. 2015;34(9):1456-1463. [DOI] [PubMed] [Google Scholar]
- 49. Centers for Disease Control and Prevention. Health Equity Guiding Principles for Inclusive Communication. Centers for Disease Control and Prevention; 2022. Accessed March 9, 2023. https://wwwcdcgov/healthcommunication/Health_Equityhtml [Google Scholar]
- 50. Gómez CA, Kleinman DV, Pronk N, et al. Addressing health equity and social determinants of health through healthy people 2030. J Public Health Manag Pract. 2021;27(6):S249-S257. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 51. Bodenheimer T, Wagner EH, Grumbach K. Improving primary care for patients with chronic illness. JAMA. 2002;288(14):1775-1779. [DOI] [PubMed] [Google Scholar]
- 52. Di Bitetti MS, Ferreras JA. Publish (in English) or perish: the effect on citation rate of using languages other than English in scientific publications. Ambio. 2017;46:121-127. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 53. Rothman KJ. Causes. Am J Epidemiol. 1976;104(6):587-592. [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Supplementary Materials
Supplemental material, sj-docx-1-gph-10.1177_30502225261421700 for The Gap in Integrated Pediatric Care: A Systematic Review of Family-Based Weight Management for Children Living with HIV by Joshua S. Yudkin, Christopher Owens, James Gilbreath and Charles Martyn-Dickens in Sage Open Pediatrics